Phytopathology 77:1192–1198 Cooke DEL, Lees AK (2004) Markers, old and new, for examining Phytophthora infestans diversity. Plant Pathology 53:692–704 Cooke DEL, Drenth A, Duncan JM, Wagels G, Brasier CM (2000) A molecular phylogeny of Phytophthora and related oomycetes. Fungal Genet Biol 30:17–32PubMed De Cock AW, Mendoza L, Padhye AA, Ajello L, Kaufman L (1987)

Pythium insidiosum sp. nov., Acalabrutinib manufacturer the etiologic agent of pythiosis. J Clin Microbiol 25:344–349PubMed Dick MW (1990) Keys to Pythium. M. W. Dick, Reading Dick MW (2001) Straminipilous Fungi: systematics of the Peronosporomycetes including accounts of the marine straminipilous protists, the Plasmodiophorids and similar organisms. Kluwer, Dordrecht Dick MW, Vick MC, Gibbings JG, Hedderson TA, Lopez-Lastra CC (1999) 18S rDNA for species of Leptolegnia and other Peronosporomycetes: justification for the subclass BMN 673 price taxa

Saprolegniomycetidae and Peronosporomycetidae and division of the Saprolegniaceae sensu lato into the Leptolegniaceae and Saprolegniaceae. Mycol Res 103:1119–1125 Erwin DC, Ribeiro OK (1996) Phytophthora diseases worldwide. American Phytopathological Society, St. Paul Forbes GA, Goodwin SB, Drenth A, Oyarzun P, Ordoñez ME, Fry WE (1998) A global marker database for Phytophthora infestans. Plant Dis 82:811–818 Förster H, Kinscherf TG, Leong SA, Maxwell DP (1989) Restriction fragment length polymorphisms of the mitochondrial DNA of Phytophthora megasperma isolated from soybean, alfalfa, and fruit trees. Can J Bot 67:529–537 Förster H, Coffey MD, Elwood H, Sogin ML (1990) Sequence analysis of the small subunit ribosomal RNAs of the three zoosporic fungi and implications for fungal evolution. Mycologia 82:306–312 Fry WE, Goodwin SB (1997) Re-emergence of potato and tomato late blight in the United States and Canada. http://www.selleck.co.jp/products/Fludarabine(Fludara).html Plant Dis 81:1349–1357 Fry WE, Goodwin SB, Matuszak JM, Spielman LJ, Milgroom MG, Drenth A (1992) Population genetics and intercontinental migrations of Phytophthora infestans. Annu Rev Phytopathol 30:107–129

Gäumann E (1923) Beiträge zu einer Monographie der Gattung Peronospora. Beiträge zur Kryptogamenflora der Schweiz 5:1–360 Gavino PD, Smart CD, Sandrock RW, Miller JS, Hamm PB, Lee TY, Davis RM, Fry WE (2000) Implications of sexual reproduction for Phytophthora infestans in the United States: Generation of an aggressive lineage. Plant Dis 84:731–735 Gomez-Alpizar L, Carbone I, Ristaino JB (2007) An Andean origin of Phytophthora infestans inferred from mitochondrial and nuclear gene genealogies. Proc Natl Acad Sci U S A 104:3306–3311PubMed Goodwin PH, Kirkpatrick BC, Duniway JM (1989) Cloned DNA probes for identification of Phytophthora parasitica. Phytopathology 79:716–721 Goodwin PH, English JT, Neher DA, Duniway JM, Kirkpatrick BC (1990a) Detection of Phytophthora parasitica from soil and host tissue with a species-specific DNA probe.

Nevertheless, the observed photocurrent density for the cell with Cu2S as CE is comparable with the published result of 3.06 mA/cm2[24]. In general, CdS QDSSCs

exhibit low fill factors (less than 40%) with any of the tested CE materials. Figure 1 J-V curves of CdS-based QDSSCs with various CEs. Table 1 Performance parameters of CdS QDSSCs with various CEs   J SC (mA/cm2) V OC (V) FF (%) η (%) Pt 6.09 0.460 38 1.06 Graphite 6.89 0.485 36 1.20 Carbon soot 6.62 0.515 34 1.16 Cu2S 3.70 0.280 28 0.29 RGO 3.35 0.380 29 0.37 In the study of CdSe QDSSCs, J-V curves of each solar cell combination with different CE materials are shown in Figure 2, and the corresponding performance data are summarized in Table 2. Unlike the CdS QDSSC, the CdSe QDSSC exhibits high efficiencies with Hydroxychloroquine order Cu2S and platinum as CE materials. Among these results, the best performance is observed in solar cell assembly with commercial platinum catalyst as the CE. The CdSe QDSSC with platinum as the CE produced an efficiency of 1.41% followed by 1.16% with Cu2S as the CE. The fill factor and V OC with Cu2S are also good. These results show that Cu2S is compatible with CdSe QD as a CE material. On the other hand, carbon-based materials like graphite and carbon soot which work well in the NVP-BKM120 CdS QDSSC perform

poorly when coupled with CdSe QD-sensitized TiO2 electrodes. The poor performance from these materials could be attributed to the low electrocatalytic activity at the CE/electrolyte interface against the fast electron injection and transfer from CdSe QDs into the photoanode substrate. The preference of different CE materials for CdS and CdSe QD-sensitized TiO2 electrodes

could be explained by electrochemical MTMR9 impedance spectroscopy (EIS) study. The observed performance of our QDSSC is rather low when compared with result from other groups. However, we anticipate the performance to be better if optimization of the photoanode is carried out such as addition of a scattering layer and passivation with a ZnS layer. Figure 2 J-V curves of CdSe QDSSCs with various CEs. Table 2 CdSe QDSSC performance parameters with various CEs   J SC (mA/cm2) V OC (V) FF (%) η (%) Pt 6.80 0.470 44 1.41 Graphite 5.53 0.415 22 0.50 Carbon soot 1.58 0.310 15 0.07 Cu2S 6.01 0.430 45 1.16 RGO 5.15 0.415 31 0.66 EIS is performed to understand the kinetic processes within the QDSSC. Typically, an EIS spectrum for a dye-sensitized solar cell (DSSC) consists of three semicircles in the Nyquist plot [25]. This characteristic is also applicable to QDSSC [24]. The three semicircles correspond to the response in high-frequency, intermediate-frequency and low-frequency regions when the cell is biased at its open-circuit potential.

Absences were only counted as such when sufficient counts were carried out during the flight period. Relative colonization frequencies were then calculated on an annual basis

between 1992 and 2008 as the number of transects with colonizations relative to the total number of actively counted transects where the species might be expected, i.e. where it had been sighted in the period 1990–2008. Data on daily temperature (mean and maximum; in °C), radiation (in J/cm2, converted to temperature differences in °C), cloudiness (in octants, converted to %), and wind speed (in m/s, converted to Bft) were obtained from the Royal Netherlands Meteorological Institute (www.​knmi.​nl) selleck screening library for the flight periods of the three species. For each year, we averaged the weather variables over the flight periods. The effects of average weather variables on colonization frequencies were tested using regression analysis with generalized linear models in R 2.7.0. We corrected for possible effects of density dependence by taking national population numbers (as indices) into consideration. The effect of both the current and the previous year’s weather was included (see also Roy et al. 2001). The current year’s weather is assumed to affect dispersal propensity of individuals that will subsequently be

Selumetinib concentration sighted on a transect, newly colonized due to their dispersal. The previous year’s weather is assumed to affect dispersal propensity of individuals that will subsequently reproduce on a transect, newly colonized after their dispersal; their offspring will be sighted in the following year. Results Survival analysis Results of the survival analysis are on tendencies to stop flying (behaviour type: flying; Table 3) or

to start flying (behaviour type non-flying; Table 4). A greater tendency to stop flying implies shorter flight duration. The duration of flying bouts extended with high temperatures (C. pamphilus, P = 0.01; M. jurtina, P = 0.013). Intermediate and high radiation extended duration of flying bouts for P. argus (P = 0.011, P = 0.002 resp.), but high radiation showed negative effects on the duration of flying bouts for C. pamphilus (P = 0.01). Intermediate and Metalloexopeptidase high cloudiness reduced the duration of flying bouts (M. athalia, P = 0.002, P = 0.001 resp.; C. pamphilus, P = 0.017 for high cloudiness only). Intermediate and high wind speed also showed negative effects on the duration of flying bouts (C. pamphilus, P = 0.006, P = 0.0004 resp.) In general, males exhibited longer flights than females (C. pamphilus, P = 0.014) and in 2007, flight durations were longer (M. jurtina, P = 0.005; M. athalia, P = 0.025). Table 3 Results survival analysis for flight behaviour based on multivariate Cox’s proportional hazards model Covariate Species C. pamphilus (n = 853) M. jurtina (n = 420) Coef P l:i:h Coef P l:i:h Gender (male) −0.241 0.014   −0.101 0.53   Year (2007) −0.

Osteoporos Int 19:1093–1097PubMedCrossRef

7. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R (1989) Falls and Parkinson’s disease. Clin Neuropharmacol 12:98–105PubMedCrossRef 8. Kamide N, Fukuda M, Miura H (2008) The relationship between bone density and the physical performance of ambulatory patients with Parkinson’s disease. J Physiol Anthropol 27:7–10PubMedCrossRef 9. Sato Y, Kaji M, Tsuru T, Oizumi K (2001) Risk factors for hip fracture among elderly patients with Parkinson’s disease. J Neurol Sci 182:89–93PubMedCrossRef 10. Bezza A, Ouzzif Z, Naji H, Achemlal L, Mounach A, Nouijai M, Bourazza A, Mossadeq R, El MA (2008) Prevalence PF-02341066 concentration and risk factors of osteoporosis in patients with Parkinson’s disease. Rheumatol Int 28:1205–1209PubMedCrossRef 11. Bachmann CG, Trenkwalder C (2006) Body weight in patients with Parkinson’s disease. Mov Disord 21:1824–1830PubMedCrossRef 12. Woodford H, Walker R (2005) Emergency hospital admissions in idiopathic RO4929097 supplier Parkinson’s disease. Mov Disord 20:1104–1108PubMedCrossRef 13. van Dijk JG, Haan J, Zwinderman K, Kremer B, van Hilten BJ,

Roos RA (1993) Autonomic nervous system dysfunction in Parkinson’s disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry 56:1090–1095PubMedCrossRef 14. Homann CN, Wenzel K, Suppan K, Ivanic G, Kriechbaum N, Crevenna R, Ott E (2002) Sleep attacks in patients taking dopamine agonists: review. BMJ 324:1483–1487PubMedCrossRef 15. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O (2005) Sleep and sleepiness in patients with Parkinson’s disease before and find more after dopaminergic treatment. Eur J Neurol 12:199–207PubMedCrossRef 16. Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease. Am J Med 118:1250–1255PubMedCrossRef 17. Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 81:153–161PubMedCrossRef 18. Naliato EC, Violante AH, Caldas D, Farias ML, Bussade I, Lamounier FA, Loureiro CR, Fontes R, Schrank Y, Loures T, Colao

A (2008) Bone density in women with prolactinoma treated with dopamine agonists. Pituitary 11:21–28PubMedCrossRef 19. Lieberman A (2006) Depression in Parkinson’s disease—a review. Acta Neurol Scand 113:1–8PubMedCrossRef 20. Brandt-Christensen M, Garcia LA, Morkeberg NF, Kragh AP, Vedel KL (2007) Parkinson’s disease and antidepressant drug treatment: a case-register study. Parkinsonism Relat Disord 13:406–410PubMedCrossRef 21. Vestergaard P, Rejnmark L, Mosekilde L (2008) Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 82:92–101PubMedCrossRef 22. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS (1999) Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:484–490PubMedCrossRef 23.

05). A post-hoc, all pairwise multiple comparison procedure (Tukey Test) was performed for statistical analysis of significance. Tissue cytokine transcript analysis Files from the Luminex® and Open® Array analyses were parsed and organized into tab-delimited files using custom perl scripts. Values across multiple days and sexes were averaged to result in one value for each of 6 experimental conditions (Control, L-MAP, K-MAP, L-NP-51, K-MAP + L-NP-51 and L-MAP + L-NP-51). Targets (cytokines or transcripts)

that gave reliable results above background were included in the final analysis. All values were normalized to control values and expressed as log base 2. Gut microbiota analysis For microbiota analysis, .sff files generated from 454 sequencing were demultiplexed, converted to .fastq files and resulting sequences were trimmed and mapped to 16S ribosomal DNA Selleck Sirolimus intergenic regions to classify the origin

of the sequence. The methodology associated with 454 sequencing were conducted by Research and Laboratory Testing (Lubbock, TX) according to protocols previously developed and described by Dowd et al., [44]. Sequencing data were deposited to GenBank short reads archive (SRA056455). The percent of sequences Bioactive Compound Library clinical trial from each organism in each sample was normalized across all samples and final values were normalized to control and values were expressed as log base 2 of the difference between each sample and the control. A custom R script was written to perform a Pearson correlation between the relative abundance of each genus and relative abundance of each cytokine; geni with p-values of <0.05 in the Pearson and at least one cytokine from the Luminex® analysis were included in the final table, separated based on whether the r-value was positive (positive correlation) or negative

(negative correlation). Acknowledgements We would like to thank Nutrition Physiology Incorporated (NPC) and the Centers of Excellence support for mafosfamide the International Center for Food Industry Excellence for their contributions towards this study, including Dr. Doug Ware from NPC. We would also like to thank the TTU Core Facility and TTU Molecular Pathology Program for their assistance and contributions. Additionally, the authors would like to thank the TTU/HHMI Undergraduate Research Program for their support of David Campos. We would like to thank Dr. Judith Stabel at the NADC and Drs. Mohamed Osman and Don Beitz at ISU for their contributions. Funding Nutrition Physiology Incorporated provided funding for this study, including some salary for Mindy M. Brashears, Enusha Karunasena, Estevan Kiernan, Russell Lackey, and Paresh Kurkure. References 1.

Am J Surg 2002, 183:622–629.PubMedCrossRef 117. Rotondo MF, Schwab CW, McGonigal MD, Phillips GR 3rd, Fruchterman TM, Kauder DR, Latenser BA, Angood PA: ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35:375–382. see more discussion 382–373.PubMedCrossRef 118. Rotondo

MF, Zonies DH: The damage control sequence and underlying logic. Surg Clin North Am 1997, 77:761–777.PubMedCrossRef 119. Davis JW, Kaups KL, Parks SN: Base deficit is superior to pH in evaluating clearance of acidosis after traumatic shock. J Trauma 1998, 44:114–118.PubMedCrossRef 120. Davis JW, Parks SN, Kaups KL, Gladen HE, O’Donnell-Nicol S: Admission base deficit predicts check details transfusion requirements and risk of complications. J Trauma 1996, 41:769–774.PubMedCrossRef 121. Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J: Lactate clearance and survival following injury. J Trauma 1993, 35:584–588. discussion 588–589.PubMedCrossRef 122. Pape HC, Hildebrand F, Pertschy S, Zelle B, Garapati R, Grimme K, Krettek C, Reed RL 2nd: Changes

in the management of femoral shaft fractures in polytrauma patients: from early total care to damage control orthopedic surgery. J Trauma 2002, 53:452–461. discussion 461–452.PubMedCrossRef 123. Giannoudis PV, Veysi VT, Pape HC, Krettek C, Smith MR: When should we operate on major fractures in patients with severe head injuries? Am J Surg 2002, 183:261–267.PubMedCrossRef 124. Keel M, Labler L, Trentz O: “”Damage Control”" in Severely Injured Patients: Why, when, and How? Eur J Trauma 2005, 31:212–221.CrossRef 125. Pape HC, van Griensven M, Rice J, Gansslen A, Hildebrand F, Zech S, Winny M, Lichtinghagen R, Krettek C: Major secondary surgery in blunt trauma patients and perioperative PRKACG cytokine liberation: determination of the clinical relevance of biochemical markers. J Trauma 2001, 50:989–1000.PubMedCrossRef 126. Lendemans S, Kreuzfelder E, Waydhas C, Nast-Kolb D, Flohe S: [Clinical course and prognostic significance of immunological and functional parameters after severe trauma]. Unfallchirurg 2004, 107:203–210.PubMedCrossRef

127. Maier B, Lefering R, Lehnert M, Laurer HL, Steudel WI, Neugebauer EA, Marzi I: Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007, 28:668–674.PubMed 128. Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, Peitzman A: Assessment of the clinical course with inflammatory parameters. Injury 2007, 38:1358–1364.PubMedCrossRef Competing interests RHG is member of the Spine Trauma Study Group, a non-profit organization funded by Medtronic Sofamor Danek, USA. RHG receives reimbursements for clinical evaluation of new implants from Medtronic. OIS received reimbursements for invited talks from Medtronic Sofamor Danek, USA.

This work was supported by the UK Medical Research Council (Programme numbers U105960371 and U123261351). The Nestlé Foundation awarded a student travel grant for Ms Tsoi. Conflicts ICG-001 ic50 of interest None Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. References 1. Kent GN, Price

RI, Gutteridge DH, Allen JR, Blakeman SL, Bhagat CI, St John A, Barnes MP, Smith M, Evans DV (1991) Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnover. Miner Electrolyte Metab 17:1–7PubMed 2. Gertner JM, Coustan DR, Kliger AS, Mallette LE, Ravin N, Broadus AE (1986) Pregnancy Bafilomycin A1 mouse as state of physiologic absorptive hypercalciuria. Am J Med 81:451–456PubMedCrossRef 3. Olausson H, Goldberg G, Laskey M, Schoenmakers I, Jarjou L, Prentice A (2012) Calcium and bone metabolism in human pregnancy and lactation. Nutr Res Rev 25:40–67PubMedCrossRef 4. Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 40:795–826PubMedCrossRef

5. Jarjou LM, Laskey MA, Sawo Y, Goldberg GR, Cole TJ, Prentice A (2010) Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. Am J Clin Nutr 92:450–457PubMedCrossRef 6. Olausson H, Laskey MA, Goldberg GR, Prentice A (2008) Changes in bone mineral status and tetracosactide bone size during pregnancy and the

influences of body weight and calcium intake. Am J Clin Nutr 88:1032–1039PubMed 7. Prentice A, Jarjou LM, Cole TJ, Stirling DM, Dibba B, Fairweather-Tait S (1995) Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion. Am J Clin Nutr 62:58–67PubMed 8. Kovacs CS (2011) Bone development in the fetus and neonate: role of the calciotropic hormones. Curr Osteoporos Rep 9:274–283PubMedCrossRef 9. Brannon PM, Picciano MF (2011) Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 31:89–115PubMedCrossRef 10. Simmonds CS, Kovacs CS (2010) Role of parathyroid hormone (PTH) and PTH-related protein (PTHrP) in regulating mineral homeostasis during fetal development. Crit Rev Eukaryot Gene Expr 20:235–273PubMedCrossRef 11. Kalkwarf HJ, Specker BL, Ho M (1999) Effects of calcium supplementation on calcium homeostasis and bone turnover in lactating women.

6% of the sequence). Three of them (orf5, orf27, orf39) have no homologs in public databases, while 15 have homologs of unknown c-Met inhibitor function. The functions of the remaining ORFs were predicted from their similarities to known protein coding sequences. Features of these ORFs, including their position, transcriptional orientation, the size of the encoded proteins, and their closest known homologs, are summarized in Additional file 1: Table S1). Figure 1 Linear map showing the genetic structure of circular plasmid pZM3H1. The predicted genetic modules are indicated by white rectangles: REP – replication system, CZC – cobalt, zinc and cadmium resistance

module, β – putative beta-lactamase, MER – mercury resistance

module, TA – toxin-antitoxin system, MOB – system for mobilization for conjugal transfer, PAR – partitioning system. Arrows indicate the transcriptional orientation of the genes. The plot shows the G+C content of the pZM3H1 sequence (mean value 57.6 mol%). The gray-shaded area connects genes of plasmid pZM3H1 and C. litoralis KT71 that encode orthologous proteins. Sequences and structures of cis-acting elements responsible for plasmid replication (oriV), maintenance (parS), mobilization (oriT), as well as elements of a putative transposon (IRL and res) are shown. DR – direct repeats within the REP module. Further analysis of pZM3H1 revealed its modular HDAC inhibitor structure. Within the plasmid genome it was possible to distinguish putative genetic modules responsible for (i) plasmid maintenance during – replication (REP) and stabilization, (ii) mobilization for conjugal transfer (MOB), (iii) resistance to heavy metals, and (iv) other accessory genetic information (Figure  1). Characterization of the conserved backbone of plasmid pZM3H1 The backbone of pZM3H1 is composed of (i) a REP module (orf1), (ii) a MOB module (orf32) and two types of stabilization module, namely (iii) PAR (orf34-orf35), encoding

a partitioning system responsible for the correct distribution of plasmid molecules into daughter cells upon cell division, and (iv) TA (orf28-orf29), encoding a toxin and antitoxin involved in postsegregational elimination of plasmid-less cells (Figure  1). The REP module of pZM3H1 carries a single ORF (orf1) encoding a predicted protein with similarities to the RepA replication initiation proteins of several bacterial plasmids, including two well characterized members of the IncU incompatibility group: plasmid RA3 of Aeromonas hydrophila[45] and Rms149 of Pseudomonas aeruginosa[46]. The predicted RepA of pZM3H1 (as well as other related replication proteins) contains a putative helix-turn-helix (HTH) motif (FSYRKIATAMETSVSQVQRMLT; residues 420–441) located within the C-terminal part of the protein. The putative repA gene (orf1) is bordered on both sides by stretches of A+T-rich sequence (AT content of approx. 47.5%).

From 4,4′-dichloro-3,3′-diquinolinyl sulfide (11) A solution of sulfide 11 (0.18 g, 0.5 mmol) and p-fluoroaniline (0.17 g, 1.5 mmol) in MEDG (5 mL) was refluxed for 3 h. After cooling, the solution was poured into water (20 ml) and alkalized with 5 % aqueous sodium hydroxide to pH

10. The resulting solid was filtered off, washed with water and purified by column BAY 73-4506 chromatography (Al2O3, CHCl3) to give 0.17 g (86 %) of 14-(p-fluorophenyl)diquinothiazine (12c), beige, mp 315–316 °C. 1H NMR (CDCl3) δ: 6.43 (dd, 2H, C6H2), 6.77 (m, 2H, C6H2), 7.75 (t, 2H, H-2, H-12), 7.85 (t, 2H, H-3, H-11), 8.34 (d, 2H, H-4, H-10), 8.39 (d, 2H, H-1, H-13), 9,06 (s, 2H, H-6, H-8). 13C NMR (CDCl3) δ: 115.75 (J = 22.5 Hz, m-C of C6H4F), 116.30 (J = 7.5 Hz, o-C of C6H4F), 122.87 (C-1, C-13), check details 126.82 (C-13a, C-14b), 128.51 (C-2, C-12), 129.89 (C-6a, C-7a), 130.13 (C-3, C-11), 130.25 (C-4, C-10), 140.57 (J = 2.5 Hz, ipso-C

of C6H4F), 145.54 (C-13b, C-14a), 147.98 (C-4a, C-9a), 149.49 (C-6, C-8), 158.07 (J = 238.5 Hz, p–C of C6H4F). EIMS m/z: 395 (M+, 100), 363 (M-S,20), 300 (M-C6H4F, 17). Anal. Calcd. for C24H14FN3S: C, 72.89; H, 3.57; N, 10.63. Found: C, 72.77; H, 3.59; N, 10.46. In vitro lipid peroxidation Heat-inactivated hepatic microsomes from untreated rats were prepared as described (Rekka et al., 1989). The incubation mixture contained microsomal fraction (corresponding to 2.5 mg of hepatic protein per ml or 4 mM fatty acid residues), ascorbic acid (0.2 mM) in Tris–HCl/KCl buffer (50 mM/150 mM, pH 7.4), and the studied

compounds (50–1 μM) dissolved in DMSO. The reaction was initiated by addition of a freshly prepared FeSO4 solution (10 μΜ), and the mixture was incubated at 37 °C for 45 min. Lipid peroxidation of aliquots was assessed spectrophotometrically (535 against 600 nm) as TBAR. Both compounds and solvents were found not to interfere with the assay. Each assay was performed in duplicate, and IC50 values represent the mean concentration of compounds that inhibit the peroxidation of control microsomes by 50 % after 45 min of incubation. All standard errors are within 10 % of the respective reported values. Calculation of lipophilicity, molecular mass, surface area, and molecular volume Lipophilicity (as cLogP), molecular mass Bcl-w (M), surface area (S), and molecular volume (VM) were calculated using CS Chem 3D Ultra 7.0 (CambridgeSoft) and Spartan’04 (Wavefunction, Inc. Irvine, CA). Results and discussion Synthesis The synthesis of the title azaphenothiazines was based on the reactions of isomeric diquinodithiins, dichlorodiquinolinyl sulfides, and disulfide with amines, ammonia, and acetamide. The fusion reactions of linearly condensed diquinodithiin 1 with hydrochlorides of aniline and its p-substituted derivatives such as p-chloroaniline and p-methoxyaniline led to tetracyclic 9-substituted 6H-quinobenzothiazines 3a–c (Scheme 1).